EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study

Sylvia von Mackensen iD, Carolin Moorthi iD, Ronald Fischer iD, Susan Halimeh iD, Christine Heller, Wolfgang Miesbach iD, Freimut H Schilling iD, Cornelia Wermes, Guenter Auerswald iD, WIL‐QoL study group

Haemophilia · 2026-01 · 32 (1) · 143-154

DOI: 10.1111/hae.70073 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Haemophilia, online erschienen am 28.11.2025. Verfasst von Sylvia von Mackensen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Psychology, University Medical Centre of Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Quality of Life, von Willebrand Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSL Behring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Assessment of health‐related quality of life (HRQoL) is relatively new in von Willebrand disease (VWD). So far, generic questionnaires have mainly been used for HRQoL assessment in VWD.

Aims

To assess generic and disease‐specific HRQoL in adult VWD patients and compare HRQoL with the general German population.

Methods

Patients presenting with a personal or family history of bleeding and von Willebrand factor (VWF)‐specific laboratory parameters were enrolled in the WIL‐QoL study. HRQoL was assessed with generic (SF‐36) and disease‐specific (VWD‐QoL) questionnaires. Descriptive and inferential statistical procedures were applied based on a significance level at α ≤ 5%.

Results

In the retrospective, multicentre WIL‐QoL study, HRQoL and clinical data in 120 adults with VWD (one adolescent completed the adult questionnaire) from 10 centres in Germany were collected. Compared to the corresponding age group in the general German population, female VWD patients had significantly worse HRQoL in all SF‐36 domains and male patients only in the ‘physical functioning’ domain. In the VWD‐QoL, highest impairments were seen in all VWD patients in the domains ‘other physicians’, ‘treatment’ and ‘sport & leisure’. VWD patients with a more significant disease burden, such as a bleeding score ≥ 9 ( p < 0.0001), long‐term prophylaxis ( p = 0.003), and VWD‐type 3 ( p = 0.022), reported significantly worse HRQoL. No HRQoL differences were seen between male and female VWD patients.

Conclusion

Female VWD patients showed significant impairments in their HRQoL compared to the age group‐related general population. Compared to SF‐36, the VWD‐QoL identified stronger significant HRQoL differences in most VWD subgroups, confirming the impact of bleeds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of Lifevon Willebrand DiseasesHumansFemaleMaleAdultGermanyMiddle AgedSurveys and QuestionnairesYoung AdultAdolescentRetrospective StudiesAged

Stichwörter der Autor:innen

VWD typeVWD‐QoLbleeding scoredisease‐specific questionnairehealth‐related quality of lifelong‐term prophylaxis

Autor:innen und Institutionen

  • Department of Medical Psychology, University Medical Centre of Hamburg-Eppendorf, Hamburg, Germany.
  • Coagulation Centre, Bremen Central Clinic, GeNo Ltd., Parent-Child-Centre Prof. Hess, Bremen, Germany.
  • Haemophilia Centre, University Hospital Giessen/Marburg, Giessen, Germany.
  • SRH Haemophilia Treatment Centre, SRH Kurpfalz-Hospital Heidelberg, Heidelberg, Germany.
  • Coagulation Centre Rhine-Ruhr, Duisburg, Germany.
  • Department of Paediatrics, Paediatric Haemophilia Centre, Goethe University, University Hospital Frankfurt, Frankfurt/Main, Germany.

ORCID-Profile: Sylvia von Mackensen, Carolin Moorthi, Ronald Fischer, Susan Halimeh, Wolfgang Miesbach, Freimut H Schilling, Guenter Auerswald

Förderung

  • CSL Behring

Zitieren

APA

von Mackensen, S., Moorthi, C., Fischer, R., Halimeh, S., Heller, C., Miesbach, W., Schilling, F. H., Wermes, C., Auerswald, G., & WIL‐QoL study group (2026). Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study. Haemophilia, 32(1), 143-154. https://doi.org/10.1111/hae.70073

Vancouver

von Mackensen S, Moorthi C, Fischer R, Halimeh S, Heller C, Miesbach W, et al. Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study. Haemophilia. 2026;32(1):143-154. doi:10.1111/hae.70073

BibTeX
@article{vonMackensen2026,
  author = {von Mackensen, Sylvia and Moorthi, Carolin and Fischer, Ronald and Halimeh, Susan and Heller, Christine and Miesbach, Wolfgang and Schilling, Freimut H and Wermes, Cornelia and Auerswald, Guenter and WIL‐QoL study group, WIL‐QoL study group},
  title = {Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study},
  journal = {Haemophilia},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {143--154},
  doi = {10.1111/hae.70073}
}
Kostenlos starten →